Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
The temporal dynamics of relapse and reinfection tuberculosis after successful treatment: A retrospective cohort study
Clinical Infectious Diseases, Volume 58, No. 12, Year 2014
Notification
URL copied to clipboard!
Description
Background. There is increasing evidence from tuberculosis high-burden settings that exogenous reinfection contributes considerably to recurrent disease. However, large longitudinal studies of endogenous reactivation (relapse) and reinfection tuberculosis are lacking. We hypothesize a relationship between relapse vs reinfection and the time between treatment completion and recurrent disease.Methods. Population-based retrospective cohort study on all smear-positive tuberculosis cases successfully treated between 1996 and 2008 in a suburban setting in Cape Town, South Africa. Inverse gaussian distributions were fitted to observed annual rates of relapse and reinfection, distinguished by DNA fingerprinting of Mycobacterium tuberculosis strains recultured from diagnostic samples.Results. Paired DNA fingerprint data were available for 130 (64%) of 203 recurrent smear-positive tuberculosis cases in the 13-year study period. Reinfection accounted for 66 (51%) of 130 recurrent cases overall, 9 (20%) of 44 recurrent cases within the first year, and 57 (66%) of 86 thereafter (P <. 001). The relapse rate peaked at 3.93% (95% confidence interval [CI], 2.35%-5.96%) per annum 0.35 (95% CI,. 15-.45) years after treatment completion. The reinfection tuberculosis rate peaked at 1.58% (95% CI,. 94%-2.46%) per annum 1.20 (95% CI,. 55-1.70) years after completion.Conclusions. To our knowledge, this is the first study of sufficient size and duration using DNA fingerprinting to investigate tuberculosis relapse and reinfection over a lengthy period. Relapse occurred early after treatment completion, whereas reinfection dominated after 1 year and accounted for at least half of recurrent disease. This temporal relationship may explain the high variability in reinfection observed across smaller studies. We speculate that follow-up time in antituberculosis drug trials should take reinfection into account. © 2014 The Author.
Authors & Co-Authors
Marx, Florian M.
South Africa, Stellenbosch
Stellenbosch University
Germany, Berlin
Charité – Universitätsmedizin Berlin
Dunbar, Rory
South Africa, Stellenbosch
Stellenbosch University
Enarson, Donald A.
South Africa, Stellenbosch
Stellenbosch University
France, Paris
International Union Against Tuberculosis and Lung Disease
Williams, Brian Gerard
South Africa, Stellenbosch
Stellenbosch University
Warren, Robin Mark
South Africa, Stellenbosch
Stellenbosch University
Van Der Spuy, Gian D.
South Africa, Stellenbosch
Stellenbosch University
Van Helden, Paul D.
South Africa, Stellenbosch
Stellenbosch University
Beyers, Nulda
South Africa, Stellenbosch
Stellenbosch University
Statistics
Citations: 123
Authors: 8
Affiliations: 3
Identifiers
Doi:
10.1093/cid/ciu186
ISSN:
10584838
e-ISSN:
15376591
Research Areas
Genetics And Genomics
Study Design
Cross Sectional Study
Cohort Study
Study Approach
Quantitative
Study Locations
South Africa